MADHAVBAUGVaidya Sane Ayur Lab

₹273.5-2.32%

Market Cap

₹287.54 Cr

Stock P/E

40.30

ROCE

8.14%

ROE

4.82%

Book Value

₹40.11

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Domestic Investors

Public

From Last Concall

POSITIVES

•
Transcript not provided in the supplied file, so no verifiable positives can be drawn.
•
No financials or strategic details disclosed in the invitation to base conclusions on.

NEGATIVES

•
Lack of transcript data prevents any analysis of earnings drivers, guidance, or Q&A quality.
•
Missing financial specifics (revenue, EBITDA, margins) required for a meaningful positives/negatives assessment.

Peers Summary

Sector Leader

In the Hospital & Healthcare Services sector, Vaidya Sane Ayurved Laboratories Ltd. shows lower revenue growth and profitability metrics compared to its peers. However, it has a very low debt-to-equity ratio. Among peers, Max Healthcare and Apollo Hospitals stand out as strong performers with significant profitability and growth metrics, while companies like Aster DM Healthcare are undervalued but financially weak. Overall, Vaidya Sane requires strategic improvements to compete effectively.

Key Points

• Max Healthcare Institute Ltd. and Apollo Hospitals Enterprise Ltd. lead in profitability and growth metrics.
• Vaidya Sane Ayurved Laboratories Ltd. has the lowest revenue growth and EPS among peers.
• Aster DM Healthcare shows a low valuation but is financially weak with significant revenue decline.

Top Performers

Max Healthcare Institute Ltd.

Highest revenue growth (18.49% YoY) and profitability metrics (ROE: 13.47%, Profit Margin: 19.56%).

Apollo Hospitals Enterprise Ltd.

Strong profitability (ROE: 20.51%, EPS: 100.56) and consistent revenue growth (14.73% YoY).

Explore

Watchlists

Command Palette